EU Approves Cargill’s ARA as Novel Food for Infants

January 6, 2012

The company’s ARA already bears FDA GRAS affirmation in the United States.

Under its infant formula directive, the European Commission has authorized Cargill’s (Minneapolis) arachidonic acid (ARA) fatty acid as a novel food for use in infant formula and formulas for older children. The company’s ARA already bears FDA GRAS affirmation in the United States.

ARA is an omega-6 long-chain polyunsaturated fatty acid that is a natural component of milk in human mothers. According to Cargill, ARA is included in most infant formulas on the market, promoting infant brain and vision development and often included in conjunction with DHA omega-3 fatty acid, at an approximate ARA:DHA ratio of 2:1.

Cargill greatly increased its ARA capacity in 2010 when it opened an ARA facility in Gedian, China, in partnership with Cargill Alking Bioengineering.

“Cargill is pleased that we now have the opportunity to help our European customers develop premium infant formulas using Cargill’s ARA,” said David Henstrom, Cargill Health & Nutrition’s vice president, in a press release.

Related Content:

Regulatory